The heterogeneity of autoantibody targets in autoimmune encephalitides presents a
challenge for understanding cellular and humoral pathophysiology, and the development of …

Major advances in our knowledge concerning autoimmune and paraneoplastic cerebellar
ataxias have occurred in the last 20 years. The discovery of several neural antibodies …

Antibodies against N-methyl-d-aspartate receptors (NMDARs) are most frequently detected
in persons with autoimmune encephalitis (AE) and used as diagnostic biomarkers …

Background Anti-IgLON5 disease is a rare neurological disorder characterized by
autoantibodies against IgLON5, and pathological evidence of neurodegeneration. IgLON5 is …

Paralleling advances with respect to more common antibody-mediated encephalitides, such
as anti-N-methyl-D-aspartate receptor (NMDAR) and anti-leucine-rich glioma-inactivated 1 …

Early first-line immunotherapies, including corticosteroids and plasma exchange, improve
outcomes, with emerging evidence showing second-line immunotherapies (especially …

A variety of neuronal surface (NS) antibodies (NS-Ab) have been identified in autoimmune
encephalitis (AE). Tissue-based assay (TBA) using a rodent brain immunohistochemistry …

Background The usefulness of current diagnostic approaches in children with suspected
autoimmune encephalitis is unknown. We aimed to assess the diagnosis of autoimmune …

Autoimmune encephalitis (AE) is a group of inflammatory conditions that can associate with
the presence of antibodies directed to neuronal intracellular, or cell surface antigens. These …

Background It is important to differentiate autoimmune cerebellar ataxia (ACA) from
neurodegenerative CA, but this is sometimes difficult. We performed a retrospective study in …